NZ180321A - Sustained release pharmaceutical preparation - Google Patents
Sustained release pharmaceutical preparationInfo
- Publication number
- NZ180321A NZ180321A NZ180321A NZ18032176A NZ180321A NZ 180321 A NZ180321 A NZ 180321A NZ 180321 A NZ180321 A NZ 180321A NZ 18032176 A NZ18032176 A NZ 18032176A NZ 180321 A NZ180321 A NZ 180321A
- Authority
- NZ
- New Zealand
- Prior art keywords
- sustained release
- pharmaceutical preparation
- release pharmaceutical
- preparation
- sustained
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US55910775A | 1975-03-17 | 1975-03-17 | |
| US65800376A | 1976-02-13 | 1976-02-13 | |
| KR7600645A KR800001387B1 (en) | 1975-03-17 | 1976-03-16 | Process for preparing sustained release formulation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ180321A true NZ180321A (en) | 1978-06-20 |
Family
ID=27348140
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ180321A NZ180321A (en) | 1975-03-17 | 1976-03-15 | Sustained release pharmaceutical preparation |
Country Status (21)
| Country | Link |
|---|---|
| JP (1) | JPS51115910A (en) |
| AR (1) | AR222624A1 (en) |
| AT (1) | AT353415B (en) |
| AU (1) | AU505355B2 (en) |
| CA (1) | CA1073358A (en) |
| CH (1) | CH630257A5 (en) |
| DD (1) | DD124102A5 (en) |
| DE (1) | DE2611041A1 (en) |
| DK (1) | DK148344C (en) |
| ES (1) | ES446075A1 (en) |
| FR (1) | FR2304354A1 (en) |
| GB (1) | GB1546448A (en) |
| GR (1) | GR60341B (en) |
| IE (1) | IE43083B1 (en) |
| LU (1) | LU74558A1 (en) |
| MC (1) | MC1101A1 (en) |
| NL (1) | NL190313C (en) |
| NZ (1) | NZ180321A (en) |
| PH (1) | PH14927A (en) |
| PT (1) | PT64907B (en) |
| SE (1) | SE433804B (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ197543A (en) * | 1980-07-02 | 1984-12-14 | Commw Scient Ind Res Org | Controlled release compositions for inclusion in intraruminal devices |
| CH649215A5 (en) * | 1981-04-29 | 1985-05-15 | Hoffmann La Roche | PHARMACEUTICAL PREPARATIONS. |
| CH652025A5 (en) * | 1981-09-14 | 1985-10-31 | Hoffmann La Roche | Pharmaceutical preparation. |
| US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
| GB2154874B (en) * | 1984-02-29 | 1987-11-04 | Sandoz Ltd | Bromoscriptine compositions |
| CH666406A5 (en) * | 1984-02-29 | 1988-07-29 | Sandoz Ag | METHOD FOR PRODUCING microcapsules BROMOKRIPTINMESYLAT AS PHARMACOLOGICAL ACTIVE INCLUDED. |
| AU4064285A (en) * | 1984-03-21 | 1985-10-11 | American Home Products Corporation | Sustained release pharmaceutical capsules |
| JPS6143108A (en) * | 1984-08-03 | 1986-03-01 | Nippon Shinyaku Co Ltd | Medicinal drug and its preparation |
| NL8600161A (en) * | 1985-02-05 | 1986-09-01 | Sandoz Ag | PHARMACEUTICAL PREPARATIONS CONTAINING 9,10-DIHYDROGOTALKALOIDS. |
| GB8524135D0 (en) * | 1985-10-01 | 1985-11-06 | Sandoz Ltd | Darodipine compositions |
| NL194822C (en) * | 1985-10-01 | 2003-04-03 | Novartis Ag | Preparation for oral administration with controlled release and method for its preparation. |
| US4786503A (en) * | 1987-04-06 | 1988-11-22 | Alza Corporation | Dosage form comprising parallel lamine |
| US4814178A (en) * | 1987-07-01 | 1989-03-21 | Sanford Bolton | Floating sustained release therapeutic compositions |
| US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
| IE64128B1 (en) * | 1990-02-26 | 1995-07-12 | Byrne Rynne Holdings Ltd | A pharmaceutical composition |
| US5629016A (en) * | 1991-01-30 | 1997-05-13 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| SK282071B6 (en) * | 1991-01-30 | 2001-10-08 | The Wellcome Foundation Limited | Water-dispersible tablet and its preparation method |
| JP2626248B2 (en) * | 1991-04-08 | 1997-07-02 | 日本新薬株式会社 | Capsule |
| ATE173159T1 (en) * | 1992-03-25 | 1998-11-15 | Depomed Systems Inc | ORAL MEDICINAL DOSAGE FORMS BASED ON HYDROXYETHYL CELLULOSE WITH DELAYED RELEASE |
| US5698226A (en) * | 1993-07-13 | 1997-12-16 | Glaxo Wellcome Inc. | Water-dispersible tablets |
| US5888540A (en) * | 1993-10-29 | 1999-03-30 | Sugden; Keith | Pharmaceutical products |
| CN1133558A (en) * | 1993-10-29 | 1996-10-16 | 雷克特和科尔曼产品有限公司 | Gelatin capsule fill able to foam |
| WO1995011667A1 (en) * | 1993-10-29 | 1995-05-04 | R.P. Scherer Corporation | Gelatin capsule fill able to foam |
| WO1995031186A1 (en) * | 1994-05-13 | 1995-11-23 | Smithkline Beecham Corporation | Method and composition for increasing calcium uptake |
| JPH10509981A (en) * | 1994-12-01 | 1998-09-29 | サイバス ファーマシューティカル，インコーポレイティド | Sustained drug delivery using powdered hydrocolloid rubber obtainable from higher plants |
| FR2820319B3 (en) * | 2001-02-08 | 2003-12-05 | Ellipse Pharmaceuticals | PROCESS FOR PRODUCING A FLOATING TABLET INCLUDING ALFUZOSINE AND TABLET OBTAINED |
| FR2820318B1 (en) * | 2001-02-08 | 2005-12-23 | Ellipse Pharmaceuticals | METHOD FOR MANUFACTURING A FLOATING COMPRESSOR INCLUDING AN ACTIVE INGREDIENT AND A COMPRESS OBTAINED |
| EP1245227A1 (en) * | 2001-03-31 | 2002-10-02 | Jagotec Ag | A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same |
| FR2874325B1 (en) * | 2004-08-19 | 2006-10-20 | Sanofi Synthelabo | PHARMACEUTICAL COMPOSITION IN THE FORM OF A GASTRIC RESISTANCE COMPRESSOR CONTAINING ALFUZOSIN |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1059624B (en) * | 1954-11-11 | 1959-06-18 | Dr Knut Jacobus Sundman | Process for the production of medicaments dispersed in a carrier substance in dosed form |
| JPS5512411B2 (en) * | 1974-03-12 | 1980-04-02 | ||
| DE2439538C3 (en) * | 1974-08-17 | 1980-07-17 | Ludwig Heumann & Co Gmbh, 8500 Nuernberg | Process for the manufacture of orally administered drugs with delayed release of action |
-
1976
- 1976-03-05 CH CH277676A patent/CH630257A5/en not_active IP Right Cessation
- 1976-03-11 IE IE508/76A patent/IE43083B1/en unknown
- 1976-03-15 NZ NZ180321A patent/NZ180321A/en unknown
- 1976-03-15 FR FR7607363A patent/FR2304354A1/en active Granted
- 1976-03-15 LU LU74558A patent/LU74558A1/xx unknown
- 1976-03-15 MC MC761182A patent/MC1101A1/en unknown
- 1976-03-15 GR GR50306A patent/GR60341B/en unknown
- 1976-03-16 DK DK113676A patent/DK148344C/en not_active IP Right Cessation
- 1976-03-16 DD DD191877A patent/DD124102A5/xx unknown
- 1976-03-16 AU AU12049/76A patent/AU505355B2/en not_active Expired
- 1976-03-16 AT AT192276A patent/AT353415B/en not_active IP Right Cessation
- 1976-03-16 CA CA248,018A patent/CA1073358A/en not_active Expired
- 1976-03-16 ES ES446075A patent/ES446075A1/en not_active Expired
- 1976-03-16 PT PT64907A patent/PT64907B/en unknown
- 1976-03-16 SE SE7603325A patent/SE433804B/en not_active IP Right Cessation
- 1976-03-16 GB GB10482/76A patent/GB1546448A/en not_active Expired
- 1976-03-16 DE DE19762611041 patent/DE2611041A1/en active Granted
- 1976-03-16 JP JP51027758A patent/JPS51115910A/en active Granted
- 1976-03-17 AR AR262597A patent/AR222624A1/en active
- 1976-03-17 NL NLAANVRAGE7602776,A patent/NL190313C/en not_active IP Right Cessation
- 1976-03-29 PH PH18224A patent/PH14927A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR222624A1 (en) | 1981-06-15 |
| DD124102A5 (en) | 1977-02-02 |
| IE43083L (en) | 1976-09-17 |
| DK148344B (en) | 1985-06-17 |
| DK113676A (en) | 1976-09-18 |
| FR2304354A1 (en) | 1976-10-15 |
| DK148344C (en) | 1985-11-04 |
| FR2304354B1 (en) | 1979-04-27 |
| JPS638084B2 (en) | 1988-02-19 |
| PT64907B (en) | 1978-03-24 |
| AU505355B2 (en) | 1979-11-15 |
| AU1204976A (en) | 1977-09-22 |
| JPS51115910A (en) | 1976-10-13 |
| CA1073358A (en) | 1980-03-11 |
| SE7603325L (en) | 1976-09-18 |
| NL190313B (en) | 1993-08-16 |
| GB1546448A (en) | 1979-05-23 |
| GR60341B (en) | 1978-05-17 |
| AT353415B (en) | 1979-11-12 |
| ATA192276A (en) | 1979-04-15 |
| DE2611041A1 (en) | 1976-10-14 |
| ES446075A1 (en) | 1977-09-16 |
| MC1101A1 (en) | 1977-02-04 |
| NL190313C (en) | 1994-01-17 |
| NL7602776A (en) | 1976-09-21 |
| LU74558A1 (en) | 1977-09-27 |
| DE2611041C2 (en) | 1988-06-09 |
| IE43083B1 (en) | 1980-12-17 |
| SE433804B (en) | 1984-06-18 |
| PH14927A (en) | 1982-01-29 |
| CH630257A5 (en) | 1982-06-15 |
| PT64907A (en) | 1976-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ180321A (en) | Sustained release pharmaceutical preparation | |
| ZA775370B (en) | Sustained release pharmaceutical composition | |
| ZA7671B (en) | Pharmaceutical composition | |
| JPS5272829A (en) | Pharmaceutical composition | |
| IL51096A0 (en) | Novel pharmaceutical dosage form | |
| ZA765931B (en) | Controlled release tablet | |
| JPS51115911A (en) | Continuous releasing medical preparation | |
| CY1153A (en) | Pharmaceutical compositions | |
| GB1549171A (en) | Pharmaceutical formulations containing hydrocy bezophenonederivatives | |
| IL53462A0 (en) | Prolonged release pharmaceutical preparations | |
| AU1306576A (en) | Pharmaceutical formulation | |
| GB1555009A (en) | Cluctch release mechanisms | |
| IE42772L (en) | Pharmaceutical compositions | |
| ZA767215B (en) | Pharmaceutical compositions | |
| GB1552416A (en) | Pharmaceutical compositions | |
| ZA761880B (en) | New pharmaceutical compositions | |
| ZA761305B (en) | Sustained release formulation | |
| ZA767193B (en) | Pharmaceutical antifertility-combinations | |
| IL47592A0 (en) | Controlled drug releasing preparation | |
| IE43955L (en) | Pharmaceutical composition | |
| IL49215A0 (en) | Sustained release pharmaceutical formulation | |
| ZA763806B (en) | Pharmaceutical compositions | |
| ZA7627B (en) | Pharmaceutical combination preparations | |
| ZA752585B (en) | Pharmaceutical composition | |
| IL49355A0 (en) | Pharmaceutical compositions comprising sodium-l-ascorbate-2-sulfate |